Valeant, Pershing eye shakeup to Allergan board

Thu May 8, 2014 9:01am EDT

May 8 (Reuters) - Deal-making drugmaker Valeant Pharmaceuticals International Inc said on Thursday that it plans with activist investor Pershing Square to pursue a special meeting to change up the board of Allergan Inc , which it hopes to acquire.

Valeant Chief Financial Officer Howard Schiller also said the company is ready to negotiate with Allergan and will commence with Pershing a referendum of Allergan shareholders on support for holding discussions with Valeant. (Reporting by Rod Nickel in Winnipeg, Manitoba, Editing by Franklin Paul)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.